Research article · 2018
Case reportPublished 28 Jan 2019
Remarkable Improvement of Glucose Variability by Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors using Continuous Glucose Monitoring (CGM)
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Authors have continued clinical research of Calorie Restriction (CR) and Low Carbohydrate Diet (LCD) and present a case with precise observation of continuous glucose monitoring (CGM). The patient is 38 years-old females with type 2 diabetes mellitus (T2DM), who showed BMI 19.6, postprandial blood glucose 277 mg/dL. HbA1c 12.6%, glycoalbumin 31.8% (11.6-16.4), HOMA-R 2.8, HOMA-β 8.5, urinary excretion of C-peptide 67 μg/day, and normal range of liver, renal, lipid exams. She was given three stage intervention. The protocol was • Day 1-2; CR meal with 60% carbohydrate, • Day 3-5; LCD meal with 12% carbohydrate, • Day 6-13; LCD+Sodium–glucose cotransporter 2(SGLT2) inhibitors (Suglat 50 mg, Ipragliflozin L-Proline). The glucose variability was monitored using FreeStyle Libre Pro (Abbott) for 14 days. Blood glucose was decreased as • More than 350 mg/dL, • 180-200 mg/dL, • 100-150 mg/dL in day 7-9, and 90-120 mg/dL in day 10-13. Acute decrease of blood glucose was found 3 hours after giving Suglat, which was remarkable finding. These results suggest the improving glucose variability of LCD in short term, the acute and strong efficacy of SGLT2 inhibitors for glucose metabolism, and clinical usefulness of simultaneous observation of glucose fluctuation.
Keywords
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2017
POSSIBLE VASCULAR AND RENAL PROTECTIVE EFFECTS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS
Mini review · 29 Jul 2022
The Effect of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors on Urinary Tract Infections
Conference abstract · 2011
Translating Glucose Variability Metrics into the Clinic via a Continuous Glucose Monitoring Graphical User Interface for Diabetes Evaluation (CGM-GUIDE)
Conference abstract · 2019
An audit of Sodium-Glucose co-Transporter 2 (SGLT2) inhibitors in a specialist outpatient service: Are the Pharmaceutical Benefits Scheme (PBS) approval guidelines too restrictive
More from this journal
The newest in Diabetes Case Reports.
Article · 19 Jun 2026
Advances in Insulin Therapy: Improving Glycemic Control in Modern Diabetes Care
Article · 19 Jun 2026
Metformin and Its Place in Modern Diabetes Care
Article · 19 Jun 2026
Preventing Diabetes Through Healthy Living and Early Action
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDiabetes Case Reports
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Koji Ebe”
- BylineArticles whose byline prints “Hiroshi Bando”
- BylineArticles whose byline prints “Tetsuo Muneta”
- BylineArticles whose byline prints “Masahiro Bando”
- BylineArticles whose byline prints “Yoshikazu Yonei”
